Brief: AngioDynamics To Sell Dialysis Product Portfolio, Biosentry Product For $100 Mln
June 8 (Reuters) - AngioDynamics Inc ANGO.O :
* ANGIODYNAMICS ANNOUNCES SALE OF DIALYSIS PRODUCT PORTFOLIO
AND
BIOSENTRY PRODUCT TO MERIT MEDICAL SYSTEMS FOR $100 MILLION
* ANGIODYNAMICS INC - PRELIMINARY FISCAL YEAR 2023 NET SALES
IN
RANGE OF $338 MILLION TO $339 MILLION
* ANGIODYNAMICS INC - TRANSACTION WILL BE DILUTIVE TO
ADJUSTED
EARNINGS PER SHARE AND IS EXPECTED TO BE SLIGHTLY DILUTIVE TO
CORPORATE GROSS MARGINS
Source text for Eikon: ID:nBw9fxd6Ma
Further company coverage: ANGO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary